Breakthrough Vaccine to Treat Advanced Stages of Ovarian Cancer

Cancer Treatment Centers of America develops patient-specific vaccine therapy Medical experts say more than 15-thousand women will die this year from ovarian cancer. But there is hope for those stricken with the disease in the form of a promising new vaccine. The breakthrough treatment, created by Cancer Treatment Centers of America and AVAX Therapeutics, Inc., uses the patient’s own tumor tissues to create a patient-specific vaccine. Combined with local chemotherapy, the treatment avoids stressing the patient’s immune system and, therefore, helps to increase the vaccine’s effectiveness. Ovarian cancer is a complex disease – it’s difficult to diagnose and often resistant to chemotherapy. The treatment will be available to women whose cancer has recurred after chemotherapy. Cancer Treatment Centers of America expects to begin treating patients this summer. A video report by Cancer Treatment Centers of America